{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,21]],"date-time":"2026-09-21T16:16:01Z","timestamp":1790007361531,"version":"4.0.1"},"reference-count":43,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2002,11,15]],"date-time":"2002-11-15T00:00:00Z","timestamp":1037318400000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Cancer"],"DOI":"10.1186\/1471-2407-2-29","type":"journal-article","created":{"date-parts":[[2003,1,9]],"date-time":"2003-01-09T12:07:46Z","timestamp":1042114066000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":131,"title":["Methylation profiling of twenty promoter-CpG islands of genes which may contribute to hepatocellular carcinogenesis"],"prefix":"10.1186","volume":"2","author":[{"given":"Jian","family":"Yu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Min","family":"Ni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jian","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongyu","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Baomei","family":"Gao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianren","family":"Gu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianguo","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lisheng","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mengchao","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sushen","family":"Zhen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jingde","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2002,11,15]]},"reference":[{"key":"49_CR1","unstructured":"Liu Q, Wang W, eds: Liver Cancer. Beijing: People's Medical Publishing House. 2000"},{"key":"49_CR2","unstructured":"Parkin DM, Whelan SL, Ferlay J, Raymond L, Young J, eds: IARC library cataloguing in publication data cancer incidence in five continents, no.143 edn. Lyon: IARC Scientific Publications. 1997"},{"key":"49_CR3","doi-asserted-by":"publisher","first-page":"S294","DOI":"10.1111\/j.1440-1746.1997.tb00513.x","volume":"12","author":"CJ Chen","year":"1997","unstructured":"Chen CJ, Yu MW, YF L: Epidemiological characteristics and risk factors of hepatocellular carcinoma. J Gastroenterol Hepatol. 1997, 12: S294-308.","journal-title":"J Gastroenterol Hepatol"},{"key":"49_CR4","doi-asserted-by":"publisher","first-page":"392","DOI":"10.1073\/pnas.98.2.392","volume":"98","author":"A Feninberg","year":"2001","unstructured":"Feninberg A: Cancer epigenetics takes center stage. Proc Natl Acad Sci USA. 2001, 98: 392-394. 10.1073\/pnas.98.2.392.","journal-title":"Proc Natl Acad Sci USA"},{"key":"49_CR5","first-page":"87","volume":"249","author":"A Feinberg","year":"2000","unstructured":"Feinberg A: DNA methylation, genomic imprinting and cancer. Curr Top Microbiol Immunol. 2000, 249: 87-99.","journal-title":"Curr Top Microbiol Immunol"},{"key":"49_CR6","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1002\/path.890","volume":"195","author":"M Paulsen","year":"2001","unstructured":"Paulsen M, Ferguson-Smith AC: DNA methylation in genomic imprinting, development, and disease. J Pathol. 2001, 195: 97-110. 10.1002\/path.890.","journal-title":"J Pathol"},{"key":"49_CR7","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1016\/S0168-9525(99)01971-X","volume":"16","author":"SB Baylin","year":"2000","unstructured":"Baylin SB, Herman JG: DNA hypermethylation in tumorigenesis: epigenetics joins genetics. Trends Genet. 2000, 16: 168-174. 10.1016\/S0168-9525(99)01971-X.","journal-title":"Trends Genet"},{"key":"49_CR8","doi-asserted-by":"publisher","first-page":"1068","DOI":"10.1126\/science.1063852","volume":"293","author":"PA Jones","year":"2001","unstructured":"Jones PA, D T: The role of DNA methylation in mammalian epigenetics. Science. 2001, 293: 1068-70. 10.1126\/science.1063852.","journal-title":"Science"},{"key":"49_CR9","first-page":"5329","volume":"60","author":"RL Baldwin","year":"2000","unstructured":"Baldwin RL, Nemeth E, Tran H, Shvartsman H, Cass I, Narod S, Karlan BY: BRCA1 promoter region hypermethylation in ovarian carcinoma: a population-based study. Cancer Res. 2000, 60: 5329-5333.","journal-title":"Cancer Res"},{"key":"49_CR10","first-page":"1211","volume":"60","author":"DJ Simpson","year":"2000","unstructured":"Simpson DJ, Hibberts NA, McNicol AM, Clayton RN, Farrell WE: Loss of pRb expression in pituitary adenomas is associated with methylation of the RB1 CpG island. Cancer Res. 2000, 60: 1211-1216.","journal-title":"Cancer Res"},{"key":"49_CR11","first-page":"501","volume":"8","author":"JK Wiencke","year":"1999","unstructured":"Wiencke JK, Zheng S, Lafuente A, Lafuente MJ, Grudzen C, Wrensch MR, Miike R, Ballesta A, Trias M: Aberrant methylation of p16INK4a in anatomic and gender-specific subtypes of sporadic colorectal cancer. Cancer Epidemiol Biomarkers Prev. 1999, 8: 501-506.","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"49_CR12","first-page":"4238","volume":"61","author":"CH Lin","year":"2001","unstructured":"Lin CH, Hsieh SY, Sheen IS, Lee WC, Chen TC, Shyu WC, Liaw YF: Genome-wide hypomethylation in hepatocellular carcinogenesis. Cancer Res. 2001, 61: 4238-4243.","journal-title":"Cancer Res"},{"key":"49_CR13","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1038\/25779","volume":"395","author":"RZ Chen","year":"1998","unstructured":"Chen RZ, Pettersson U, Beard C, Jackson-Grusby L, Jaenisch R: DNA hypomethylation leads to elevated mutation rates. Nature. 1998, 395: 89-93. 10.1038\/25779.","journal-title":"Nature"},{"key":"49_CR14","first-page":"3516","volume":"6","author":"IH Wong","year":"2000","unstructured":"Wong IH, Lo YM, Yeo W, Lau WY, Johnson PJ: Frequent p15 promoter methylation in tumor and peripheral blood from hepatocellular carcinoma patients. Clin Cancer Res. 2000, 6: 3516-3521.","journal-title":"Clin Cancer Res"},{"key":"49_CR15","first-page":"71","volume":"59","author":"IH Wong","year":"1999","unstructured":"Wong IH, Lo YM, Zhang J, Liew CT, Ng MH, Wong N, Lai PB, Lau WY, Hjelm NM, Johnson PJ: Detection of aberrant p16 methylation in the plasma and serum of liver cancer patients. Cancer Res. 1999, 59: 71-73.","journal-title":"Cancer Res"},{"key":"49_CR16","doi-asserted-by":"publisher","first-page":"5642","DOI":"10.1128\/MCB.19.8.5642","volume":"19","author":"DJ Wong","year":"1999","unstructured":"Wong DJ, Foster SA, Galloway DA, Reid BJ: Progressive region-specific de novo methylation of the p16 CpG island in primary human mammary epithelial cell strains during escape from M(0) growth arrest. Mol Cell Biol. 1999, 19: 5642-5651.","journal-title":"Mol Cell Biol"},{"key":"49_CR17","first-page":"27","volume":"61","author":"SF Hoare","year":"2001","unstructured":"Hoare SF, Bryce LA, Wisman GB, Burns S, Going JJ, van der Zee AG, Keith WN: Lack of telomerase RNA gene hTERC expression in alternative lengthening of telomeres cells is associated with methylation of the hTERC promoter. Cancer Res. 2001, 61: 27-32.","journal-title":"Cancer Res"},{"key":"49_CR18","doi-asserted-by":"publisher","first-page":"9821","DOI":"10.1073\/pnas.93.18.9821","volume":"93","author":"JG Herman","year":"1996","unstructured":"Herman JG, Graff JR, Myohanen S, Nelkin BD, Baylin SB: Methylation-specific PCR: a novel PCR assay for methylation status of CpG islands. Proc Natl Acad Sci U S A. 1996, 93: 9821-9826. 10.1073\/pnas.93.18.9821.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"49_CR19","first-page":"2704","volume":"5","author":"EP NY Xing","year":"1999","unstructured":"Xing EP NY, Song Y, Yang GY, Cai YC, Wang LD, Yang CS: Mechanisms of inactivation of p14ARF, p15INK4b, and p16INK4a genes in human esophageal squamous cell carcinoma. Clin Cancer Res. 1999, 5: 2704-13.","journal-title":"Clin Cancer Res"},{"key":"49_CR20","doi-asserted-by":"publisher","first-page":"756","DOI":"10.3346\/jkms.2001.16.6.756","volume":"16","author":"WB Chung","year":"2001","unstructured":"Chung WB, Hong SH, Kim JA, Sohn YK, Kim BW, JW K: Hypermethylation of tumor-related genes in genitourinary cancer cell lines. J Korean Med Sci. 2001, 16: 756-61.","journal-title":"J Korean Med Sci"},{"key":"49_CR21","doi-asserted-by":"publisher","first-page":"529","DOI":"10.1038\/75007","volume":"6","author":"T Teitz","year":"2000","unstructured":"Teitz T, Wei T, Valentine MB, Vanin EF, Grenet J, Valentine VA, Behm FG, Look AT, Lahti JM, Kidd VJ: Caspase 8 is deleted or silenced preferentially in childhood neuroblastomas with amplification of MYCN. Nat Med. 2000, 6: 529-535. 10.1038\/75007.","journal-title":"Nat Med"},{"key":"49_CR22","first-page":"4366","volume":"60","author":"M Esteller","year":"2000","unstructured":"Esteller M, Sparks A, Toyota M, Sanchez-Cespedes M, Capella G, Peinado MA, Gonzalez S, Tarafa G, Sidransky D, Meltzer SJ, Baylin SB, JG Herman: Analysis of adenomatous polyposis coli promoter hypermethylation in human cancer. Cancer Res. 2000, 60: 4366-4371.","journal-title":"Cancer Res"},{"key":"49_CR23","first-page":"249","volume":"61","author":"S Zochbauer-Muller","year":"2001","unstructured":"Zochbauer-Muller S, Fong KM, Virmani AK, Geradts J, Gazdar AF, Minna JD: Aberrant promoter methylation of multiple genes in non-small cell lung cancers. Cancer Res. 2001, 61: 249-255.","journal-title":"Cancer Res"},{"key":"49_CR24","doi-asserted-by":"publisher","first-page":"22322","DOI":"10.1074\/jbc.272.35.22322","volume":"272","author":"JR Graff","year":"1997","unstructured":"Graff JR, Herman JG, Myohanen S, Baylin SB, Vertino PM: Mapping patterns of CpG island methylation in normal and neoplastic cells implicates both upstream and downstream regions in de novo methylation. J Biol Chem. 1997, 272: 22322-22329. 10.1074\/jbc.272.35.22322.","journal-title":"J Biol Chem"},{"key":"49_CR25","first-page":"939","volume":"61","author":"SL Rosas","year":"2001","unstructured":"Rosas SL, Koch W, da Costa Carvalho MG, Wu L, Califano J, Westra W, Jen J, Sidransky D: Promoter hypermethylation patterns of p16, O6-methylguanine-DNA-methyltransferase, and death-associated protein kinase in tumors and saliva of head and neck cancer patients. Cancer Res. 2001, 61: 939-942.","journal-title":"Cancer Res"},{"key":"49_CR26","first-page":"3877","volume":"61","author":"KW Lo","year":"2001","unstructured":"Lo KW, Kwong J, Hui AB, Chan SY, To KF, Chan AS, Chow LS, Teo PM, Johnson PJ, Huang DP: High frequency of promoter hypermethylation of RASSF1a in nasopharyngeal carcinoma. Cancer Res. 2001, 61: 3877-3881.","journal-title":"Cancer Res"},{"key":"49_CR27","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1016\/S0304-3835(01)00499-2","volume":"169","author":"M Hattori","year":"2001","unstructured":"Hattori M, Sakamoto H, Satoh K, Yamamoto T: DNA demethylase is expressed in ovarian cancers and the expression correlates with demethylation of CpG sites in the promoter region of c-erbB-2 and SURVIVIN genes. Cancer Lett. 2001, 169: 155-164. 10.1016\/S0304-3835(01)00499-2.","journal-title":"Cancer Lett"},{"key":"49_CR28","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1038\/35051606","volume":"409","author":"MS Soengas","year":"2001","unstructured":"Soengas MS, Capodieci P, Polsky D, Mora J, Esteller M, Opitz-Araya X, McCombie R, Herman JG, Gerald WL, Lazebnik YA, Cordon-Cardo C, Lowe SW: Inactivation of the apoptosis effector Apaf1 in malignant melanoma. Nature. 2001, 409: 207-211. 10.1038\/35051606.","journal-title":"Nature"},{"key":"49_CR29","doi-asserted-by":"publisher","first-page":"1805","DOI":"10.1093\/carcin\/17.9.1805","volume":"17","author":"J Bian","year":"1996","unstructured":"Bian J, Wang Y, Smith MR, Kim H, Jacobs C, Jackman J, Kung HF, Colburn NH, Sun Y: Suppression of in vivo tumor growth and induction of suspension cell death by tissue inhibitor of metalloproteinases (TIMP3). Carcinogenesis. 1996, 17: 1805-1811.","journal-title":"Carcinogenesis"},{"key":"49_CR30","doi-asserted-by":"publisher","first-page":"1672","DOI":"10.1126\/science.274.5293.1672","volume":"274","author":"C Sherr","year":"1996","unstructured":"Sherr C: Cancer Cell Cycles. Science. 1996, 274: 1672-2677. 10.1126\/science.274.5293.1672.","journal-title":"Science"},{"key":"49_CR31","doi-asserted-by":"publisher","first-page":"1793","DOI":"10.1128\/MCB.18.4.1793","volume":"18","author":"SA Foster","year":"1998","unstructured":"Foster SA, Wong DJ, Barrett MT, Galloway DA: Inactivation of p16 in human mammary epithelial cells by CpG island methylation. Mol Cell Biol. 1998, 18: 1793-1801.","journal-title":"Mol Cell Biol"},{"key":"49_CR32","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1038\/371257a0","volume":"371","author":"GJ Hannon","year":"1994","unstructured":"Hannon GJ, Beach D: p15INK4b is a potential effector of TGF-beta-induced cell cycle arrest. Nature. 1994, 371: 257-261. 10.1038\/371257a0.","journal-title":"Nature"},{"key":"49_CR33","first-page":"987","volume":"11","author":"S DP Stone","year":"1995","unstructured":"Stone S DP, Jiang P, Weaver-Feldhaus JM, Tavtigian SV, Cannon-Albright L, Kamb A: Genomic structure, expression and mutational analysis of the P15 (MTS2) gene. Oncogene. 1995, 11: 987-991.","journal-title":"Oncogene"},{"key":"49_CR34","doi-asserted-by":"crossref","first-page":"2985","DOI":"10.1182\/blood.V91.8.2985.2985_2985_2990","volume":"91","author":"B Quesnel","year":"1998","unstructured":"Quesnel B, Guillerm G, Vereecque R, Wattel E, Preudhomme C, Bauters F, Vanrumbeke M, Fenaux P: Methylation of the p15(INK4b) gene in myelodysplastic syndromes is frequent and acquired during disease progression. Blood. 1998, 91: 2985-2990.","journal-title":"Blood"},{"key":"49_CR35","doi-asserted-by":"publisher","first-page":"686","DOI":"10.1038\/nm0795-686","volume":"1","author":"A HJ Merlo","year":"1995","unstructured":"Merlo A HJ, Mao L, Lee DJ, Gabrielson E, Burger PC, Baylin SB, Sidransky D: 5' CpG island methylation is associated with transcriptional silencing of the tumour suppressor p16\/CDKN2\/MTS1 in human cancers. Nat Med. 1995, 1: 686-692.","journal-title":"Nat Med"},{"key":"49_CR36","first-page":"4278","volume":"61","author":"AK Gupta","year":"2001","unstructured":"Gupta AK, Bakanauskas VJ, Cerniglia GJ, Cheng Y, Bernhard EJ, Muschel RJ: McKenna WG: The Ras radiation resistance pathway. Cancer Res. 2001, 61: 4278-4282.","journal-title":"Cancer Res"},{"key":"49_CR37","doi-asserted-by":"publisher","first-page":"1509","DOI":"10.1038\/sj.onc.1204175","volume":"20","author":"A Agathanggelou","year":"2001","unstructured":"Agathanggelou A, Honorio S, Macartney DP, Martinez A, Dallol A, Rader J, Fullwood P, Chauhan A, Walker R, Shaw JA, Hosoe S, Lerman MI, Minna JD, Maher ER, Latif F: Methylation associated inactivation of RASSF1a from region 3p21.3 in lung, breast and ovarian tumours. Oncogene. 2001, 20: 1509-1518. 10.1038\/sj.onc.1204175.","journal-title":"Oncogene"},{"key":"49_CR38","doi-asserted-by":"publisher","first-page":"3563","DOI":"10.1038\/sj.onc.1204469","volume":"20","author":"R Dammann","year":"2001","unstructured":"Dammann R, Takahashi T, Pfeifer GP: The CpG island of the novel tumor suppressor gene RASSF1a is intensely methylated in primary small cell lung carcinomas. Oncogene. 2001, 20: 3563-3567. 10.1038\/sj.onc.1204469.","journal-title":"Oncogene"},{"key":"49_CR39","first-page":"4556","volume":"61","author":"KO TS Toyooka","year":"2001","unstructured":"Toyooka KO TS, Virmani AK, Sathyanarayana UG, Euhus DM, Gilcrease M, Minna JD, Gazdar AF: Loss of expression and aberrant methylation of the CDH13 (H-cadherin) gene in breast and lung carcinomas. Cancer Res. 2001, 61: 4556-4560.","journal-title":"Cancer Res"},{"key":"49_CR40","first-page":"212","volume":"13","author":"LCSGo Japan","year":"1989","unstructured":"Japan LCSGo: TNM classification for hepatocellular carcinoma by Liver Cancer Study group. World J Surg. 1989, 13: 212-","journal-title":"World J Surg"},{"issue":"22","key":"49_CR41","doi-asserted-by":"publisher","first-page":"4598","DOI":"10.1093\/nar\/29.22.4598","volume":"29","author":"CT Nguyen","year":"2001","unstructured":"Nguyen CT, Gonzales FA, Jones PA: Altered chromatin structure associated with methylation-induced gene silencing in cancer cells: correlation of accessibility, methylation, MeCP2 binding and acetylation. Nucleic Acids Res. 2001, 29 (22): 4598-606. 10.1093\/nar\/29.22.4598.","journal-title":"Nucleic Acids Res"},{"issue":"11","key":"49_CR42","doi-asserted-by":"publisher","first-page":"1789","DOI":"10.1016\/S0959-8049(98)00189-0","volume":"34","author":"YW Lin","year":"1998","unstructured":"Lin YW, Chen CH, Huang GT, Lee PH, Wang JT, Chen DS, Lu FJ, Sheu JC: Infrequent mutations and no methylation of CDKN2A (P16\/MTS1) and CDKN2B (p15\/MTS2) in hepatocellular carcinoma in Taiwan. Eur J Cancer. 1998, 34 (11): 1789-95. 10.1016\/S0959-8049(98)00189-0.","journal-title":"Eur J Cancer"},{"key":"49_CR43","doi-asserted-by":"publisher","first-page":"9191","DOI":"10.1093\/nar\/12.23.9191","volume":"12","author":"JD Zhu","year":"1984","unstructured":"Zhu JD, Allan M, Paul J: The chromatin structure of the human epsilon globin gene: nuclease hypersensitive sites correlate with multiple initiation sites of transcription. Nucleic Acids Res. 1984, 12: 9191-9204.","journal-title":"Nucleic Acids Res"}],"container-title":["BMC Cancer"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1471-2407-2-29.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/1471-2407-2-29\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1471-2407-2-29","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/1471-2407-2-29.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,9,13]],"date-time":"2024-09-13T16:33:21Z","timestamp":1726245201000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmccancer.biomedcentral.com\/articles\/10.1186\/1471-2407-2-29"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2002,11,15]]},"references-count":43,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2002,12]]}},"alternative-id":["49"],"URL":"https:\/\/doi.org\/10.1186\/1471-2407-2-29","relation":{},"ISSN":["1471-2407"],"issn-type":[{"value":"1471-2407","type":"electronic"}],"subject":[],"published":{"date-parts":[[2002,11,15]]},"assertion":[{"value":"30 July 2002","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 November 2002","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 November 2002","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}],"article-number":"29"}}